Genetic manipulation of the insulin signalling cascade in mice -: potential insight into the pathomechanism of type 2 diabetes

被引:5
作者
Baudler, S
Krone, W
Brüning, JC
机构
[1] Univ Cologne, Klin 2 & Poliklin Innere Med, D-50931 Cologne, Germany
[2] Univ Cologne, Ctr Mol Med, ZMMK, D-50931 Cologne, Germany
关键词
obesity; type 2 diabetes mellitus; insulin action; insulin resistance; animal models;
D O I
10.1016/S1521-690X(03)00039-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To understand the mechanism of insulin signalling and insulin resistance in the development of type 2 diabetes, it is necessary to elucidate the role of insulin and related signal molecules in normal cellular development and functions. A technique for addressing this problem, which is growing more and more important, is the generation and characterization of knockout animal models; such models allow in vivo study of the effects of a lack of a certain gene product, for example, a hormone or intracellular signalling molecule, on the viability, development and physiology of the animal. Besides the conventional form of knockout-which abolishes expression of the gene of interest in every cell of the body and during embryonic development-more recent technology permits the selective inactivation of genes in a tissue-specific and even time-controlled manner. With these techniques, it has become possible not only to examine the function of genes whose conventional inactivation would be lethal for the animal, but also to examine the specific functions that these genes have in certain tissues or at certain developmental stages. Here, we review the phenotype of mice resulting from both conventional and conditional inactivation of molecules in the insulin signalling cascade; this work has led to novel concepts in the understanding of insulin action and the development of insulin resistance.
引用
收藏
页码:431 / 443
页数:13
相关论文
共 83 条
  • [1] Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1
    Abe, H
    Yamada, N
    Kamata, K
    Kuwaki, T
    Shimada, M
    Osuga, J
    Shionoiri, F
    Yahagi, N
    Kadowaki, T
    Tamemoto, H
    Ishibashi, S
    Yazaki, Y
    Makuuchi, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1784 - 1788
  • [2] Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
    Abel, ED
    Peroni, O
    Kim, JK
    Kim, YB
    Boss, O
    Hadro, E
    Minnemann, T
    Shulman, GI
    Kahn, BB
    [J]. NATURE, 2001, 409 (6821) : 729 - 733
  • [3] Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
    Accili, D
    Drago, J
    Lee, EJ
    Johnson, MD
    Cool, MH
    Salvatore, P
    Asico, LD
    Jose, PA
    Taylor, SI
    Westphal, H
    [J]. NATURE GENETICS, 1996, 12 (01) : 106 - 109
  • [4] ALTERNATIVE PATHWAY OF INSULIN SIGNALING IN MICE WITH TARGETED DISRUPTION OF THE IRS-1 GENE
    ARAKI, E
    LIPES, MA
    PATTI, ME
    BRUNING, JC
    HAAG, B
    JOHNSON, RS
    KAHN, CR
    [J]. NATURE, 1994, 372 (6502) : 186 - 190
  • [5] RECEPTORS FOR AND EFFECTS OF INSULIN AND IGF-I IN RAT GLOMERULAR MESANGIAL CELLS
    ARNQVIST, HJ
    BALLERMANN, BJ
    KING, GL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (03): : C411 - C416
  • [6] BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  • [7] Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes
    Bektas, A
    Warram, JH
    White, MF
    Krolewski, AS
    Doria, A
    [J]. DIABETES, 1999, 48 (03) : 640 - 642
  • [8] BERMAN JS, 1987, J IMMUNOL, V138, P2100
  • [9] Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians
    Bernal, D
    Almind, K
    Yenush, L
    Ayoub, M
    Zhang, YT
    Rosshani, L
    Larsson, C
    Pedersen, O
    White, MF
    [J]. DIABETES, 1998, 47 (06) : 976 - 979
  • [10] Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans
    Björnholm, M
    He, AR
    Attersand, A
    Lake, S
    Liu, SCH
    Lienhard, GE
    Taylor, S
    Arner, P
    Zierath, JR
    [J]. DIABETOLOGIA, 2002, 45 (12) : 1697 - 1702